Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy

Table 4 Sex hormone levels and ovarian function in patients pre- and post-radiotherapy

Characteristics	Pre-radiotherapy	Three months post-radiotherapy	One-year post-radiotherapy
E2, pg/mL	138.68 ± 90.91	68.75 ± 98.77^*	106.85 ± 126.46^&
FSH, mIU/mL	7.13 ± 6.40	55.25 ± 43.35^*	33.14 ± 40.58^&
LH, mIU/mL	9.35 ± 9.67	32.09 ± 24.49^*	20.02 ± 23.62^&
Normal ovarian function, case (rate)	77(100%)	34 (44.3%)	56(72.7%) ^#

^*Student’s t-test, Comparison of sex hormone levels with pre-radiotherapy. P < 0.01
^&Student’s t-test, Comparison of sex hormone levels with 3 months post-radiotherapy. P < 0.05
^#χ² test, Comparison of cases of normal ovarian function with 3 months post-radiotherapy. P < 0.01

ISSN: 1748-717X